Evidence map›Paper›PMID 29362015›Full record

ArticleParasitology2018

Differential virulence of camel Trypanosoma evansi isolates in mice.

Christine M Kamidi, Joanna Auma, Paul O Mireji, Kariuki Ndungu, Rosemary Bateta, Richard Kurgat, Collins Ouma, Serap Aksoy, Grace Murilla

Abstract read
In one paragraph

Article in Parasitology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Histopathology and virulence of anVeterinary world · 2023
    Article
  2. Detection ofVeterinary world · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Seroprevalence ofParasite epidemiology and control · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Christine M KamidiDepartment of Biomedical Sciences and Technology,School of Public Health and Community Development,Maseno University,Maseno,Kenya.
Joanna AumaBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Paul O MirejiBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Kariuki NdunguBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Rosemary BatetaBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Richard KurgatBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Collins OumaDepartment of Biomedical Sciences and Technology,School of Public Health and Community Development,Maseno University,Maseno,Kenya.
Serap AksoyDepartment of Epidemiology of Microbial Diseases,Yale School of Public Health,New Haven,CT,USA.
Grace MurillaBiotechnology Research Institute (BioRI) - Kenya Agricultural and Livestock Research Organization (KALRO),P.O. Box 362,Kikuyu 00902,Kenya.
Kenya Agricultural and Livestock Research Organization · KEMaseno University · KEYale University · USKenya Medical Research Institute · KE

Funding

Evolutionary Genetics of Tsetse and Its SymbiontsR01AI068932 · NIAID · YALE UNIVERSITY · PI AKSOY, SERAP, CACCONE, ADALGISA · 2008 to 2018
$7.0M
Training in Parasitology and Vector BiologyT32AI007404 · NIAID · YALE UNIVERSITY · PI TSCHUDI, CHRISTIAN · 1991 to 2017
$3.8M
Control of Tsetse Fly Transmitted Diseases in KenyaU01AI115648 · NIAID · YALE UNIVERSITY · PI AKSOY, SERAP · 2015 to 2019
$3.6M
Tsetse Transmitted African TrypanosomiasisD43TW007391 · FIC · YALE UNIVERSITY · PI AKSOY, SERAP · 2008 to 2017
$1.8M
FIC NIH HHS D43 TW007391NIAID NIH HHS R01 AI068932NIAID NIH HHS T32 AI007404NIAID NIH HHS U01 AI115648
6 · The paper itself

Abstract

This study assessed the virulence of Trypanosoma evansi, the causative agent of camel trypanosomiasis (surra), affecting mainly camels among other hosts in Africa, Asia and South America, with high mortality and morbidity. Using Swiss white mice, we assessed virulence of 17 T. evansi isolates collected from surra endemic countries. We determined parasitaemia, live body weight, packed cell volume (PCV) and survivorship in mice, for a period of 60 days' post infection. Based on survivorship, the 17 isolates were classified into three virulence categories; low (31-60 days), moderate (11-30 days) and high (0-10 days). Differences in survivorship, PCV and bodyweights between categories were significant and correlated (P < 0.05). Of the 10 Kenyan isolates, four were of low, five moderate and one (Type B) of high virulence. These findings suggest differential virulence between T. evansi isolates. In conclusion, these results show that the virulence of T. evansi may be region specific, the phenotype of the circulating parasite should be considered in the management of surra. There is also need to collect more isolates from other surra endemic regions to confirm this observation.

Indexed as

AnimalsCamelusMiceParasitemiaTrypanosomaTrypanosomiasis, AfricanVirulencePacked cell volumesurvivalTrypanosoma evansivirulence.

Identifiers

PMID29362015
PMCPMC6057853
OpenAlexW2791415806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.